>The data showed that three years after surgery there was an average 75% slowing of the disease
Can a slowing of the disease truly be considered a cure?
ag000101 on
Good news
WoodSteelStone on
>University College London’s Huntington’s disease centre
>UniQure says it will apply for a licence in the US in the first quarter of 2026 with the aim of launching the drug later that year. Conversations with authorities in the UK and Europe will start next year, but the initial focus is on the US.
5 commenti
It looks like OP posted an AMP link. These should load faster, but AMP is controversial because of [concerns over privacy and the Open Web](https://www.reddit.com/r/AmputatorBot/comments/ehrq3z/why_did_i_build_amputatorbot).
Maybe check out **the canonical page** instead: **[https://www.bbc.com/news/articles/cevz13xkxpro](https://www.bbc.com/news/articles/cevz13xkxpro)**
*****
^(I’m a bot | )[^(Why & About)](https://www.reddit.com/r/AmputatorBot/comments/ehrq3z/why_did_i_build_amputatorbot)^( | )[^(Summon: u/AmputatorBot)](https://www.reddit.com/r/AmputatorBot/comments/cchly3/you_can_now_summon_amputatorbot/)
Too late for 13
>The data showed that three years after surgery there was an average 75% slowing of the disease
Can a slowing of the disease truly be considered a cure?
Good news
>University College London’s Huntington’s disease centre
>UniQure says it will apply for a licence in the US in the first quarter of 2026 with the aim of launching the drug later that year. Conversations with authorities in the UK and Europe will start next year, but the initial focus is on the US.